Pasithea Financial Statements From 2010 to 2026

Pasithea Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 31 M 18.5 M 11.3 M Slightly volatile Other Current Liabilities 959.6 K 1.3 M 392.7 K Slightly volatile Total Current Liabilities 1.3 M 1.3 M 516.4 K Slightly volatile Total Stockholder Equity 29.1 M 17 M 10.6 M Slightly volatile Net Tangible Assets 62.1 M 59.1 M 19.4 M Slightly volatile Accounts Payable 1.2 M 1.3 M 482.1 K Slightly volatile Cash 5.9 M 6.2 M 7.3 M Slightly volatile Cash And Short Term Investments 5.9 M 6.2 M 7.3 M Slightly volatile Common Stock Shares Outstanding 1.2 M 1.3 M 868.7 K Slightly volatile Liabilities And Stockholders Equity 31 M 18.5 M 11.3 M Slightly volatile Other Current Assets 460.5 K 512.4 K 182.9 K Slightly volatile Other Stockholder Equity 52.5 M 74 M 21.7 M Slightly volatile Total Liabilities 1.9 M 1.5 M 707 K Slightly volatile Net Invested Capital 29.1 M 17 M 10.6 M Slightly volatile Total Current Assets 6.3 M 6.6 M 7.5 M Slightly volatile Capital Stock 119 125 11.8 K Slightly volatile Net Working Capital 5.3 M 5.6 M 7 M Slightly volatile Common Stock 119 125 10.7 K Slightly volatile Other Liabilities 1.2 M 1.3 M 1.4 M Slightly volatile Property Plant And Equipment Gross 140.8 K 148.2 K 131.8 K Slightly volatile Property Plant Equipment 16.1 K 18.1 K 19.8 K Slightly volatile Short and Long Term Debt Total 69.8 K 73.5 K 403.7 K Slightly volatile Net Receivables 34.6 K 36.5 K 240 K Slightly volatile Short Term Debt 96.8 K 73.5 K 142.3 K Slightly volatile Intangible Assets 6.4 M 6.6 M 8.2 M Slightly volatile Other Assets 0.8 0.9 0.9824 Slightly volatile Short Term Investments 5.5 B 6.2 B 6.8 B Slightly volatile
Pasithea Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 783.7 K 746.4 K 206.5 K Slightly volatile Other Operating Expenses 10.4 M 16.4 M 4.4 M Slightly volatile Total Operating Expenses 10.4 M 16.4 M 4.4 M Slightly volatile Selling General Administrative 7.7 M 8.1 M 468.6 M Pretty Stable Cost Of Revenue 783.7 K 746.4 K 178.8 K Slightly volatile Reconciled Depreciation 783.7 K 746.4 K 161.5 K Slightly volatile Selling And Marketing Expenses 9.5 B 9.1 B 2 B Slightly volatile
Pasithea Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation 783.7 K 746.4 K 167.6 K Slightly volatile Capital Expenditures 2.18 2.3 9.6 K Slightly volatile End Period Cash Flow 5.9 M 6.2 M 7.3 M Slightly volatile Change To Liabilities 532.1 K 506.8 K 171.2 K Slightly volatile Stock Based Compensation 662 696 416.7 K Slightly volatile Begin Period Cash Flow 28.2 M 18.8 M 9 M Slightly volatile Issuance Of Capital Stock 31 M 24.4 M 43.5 M Slightly volatile Dividends Paid 287.7 M 323.7 M 353.3 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 36.39 38.31 1.9 K Slightly volatile Dividend Yield 83.34 93.75 102 Slightly volatile PTB Ratio 0.26 0.27 132 Slightly volatile Days Sales Outstanding 181 204 223 Slightly volatile Book Value Per Share 17.72 12.14 8.4768 Slightly volatile Average Payables 919.4 K 1.7 M 423.8 K Slightly volatile Stock Based Compensation To Revenue 1.88 1.97 22.6145 Slightly volatile Capex To Depreciation 0.0578 0.0608 14.906 Pretty Stable PB Ratio 0.26 0.27 132 Slightly volatile Payables Turnover 0.55 0.52 0.1704 Slightly volatile Sales General And Administrative To Revenue 16.32 18.36 20.0359 Slightly volatile Research And Ddevelopement To Revenue 4.38 4.93 5.3813 Slightly volatile Capex To Revenue 2.33 3.96 2.1534 Slightly volatile Cash Per Share 6.9 7.26 6.4474 Slightly volatile Days Payables Outstanding 688 724 3.9 K Slightly volatile Income Quality 946.3 K 901.3 K 167.6 K Slightly volatile Intangibles To Total Assets 0.3 0.48 0.2647 Slightly volatile Net Debt To EBITDA 0.57 0.6 8.6099 Slightly volatile Current Ratio 7.19 7.57 34.0039 Slightly volatile Tangible Book Value Per Share 6.19 6.51 6.1192 Slightly volatile Receivables Turnover 1.29 1.45 1.5821 Slightly volatile Shareholders Equity Per Share 17.72 12.14 8.4768 Slightly volatile Debt To Equity 0.0038 0.004 0.0175 Slightly volatile Capex Per Share 0.0232 0.0245 0.1189 Pretty Stable Graham Net Net 5.62 5.92 5.8805 Slightly volatile Revenue Per Share 0.36 0.35 0.119 Slightly volatile Interest Debt Per Share 0.0553 0.0583 0.0578 Slightly volatile Debt To Assets 0.0034 0.0036 0.0165 Slightly volatile Enterprise Value Over EBITDA 0.29 0.3 2.0692 Slightly volatile Price Book Value Ratio 0.26 0.27 132 Slightly volatile Days Of Payables Outstanding 688 724 3.9 K Slightly volatile Ebt Per Ebit 0.7 0.88 0.9382 Slightly volatile Effective Tax Rate 0.0505 0.0568 0.062 Slightly volatile Company Equity Multiplier 0.86 0.98 1.0261 Pretty Stable Total Debt To Capitalization 0.0038 0.004 0.0172 Slightly volatile Debt Equity Ratio 0.0038 0.004 0.0175 Slightly volatile Quick Ratio 7.19 7.57 34.0048 Slightly volatile Net Income Per E B T 0.79 0.93 0.9834 Slightly volatile Cash Ratio 6.75 7.11 33.4243 Slightly volatile Days Of Sales Outstanding 181 204 223 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.14 1.1 1.0225 Slightly volatile Price To Book Ratio 0.26 0.27 132 Slightly volatile Fixed Asset Turnover 0.63 0.45 0.6604 Slightly volatile Enterprise Value Multiple 0.29 0.3 2.0692 Slightly volatile Debt Ratio 0.0034 0.0036 0.0165 Slightly volatile Price Sales Ratio 36.39 38.31 1.9 K Slightly volatile Asset Turnover 0.0102 0.0097 0.0033 Slightly volatile Price Fair Value 0.26 0.27 132 Slightly volatile
Pasithea Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 3.8 M 4 M 35.9 M Slightly volatile

Pasithea Fundamental Market Drivers

Pasithea Upcoming Events

About Pasithea Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pasithea Therapeutics is a strong investment it is important to analyze Pasithea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pasithea Therapeutics' future performance. For an informed investment choice regarding Pasithea Stock, refer to the following important reports:

How To Invest In Pasithea Details

Is Pasithea Stock a good investment? Details

What is Pasithea Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details